Updates on the Synthetic Strategies and Structure-Activity Relationship of
Anticonvulsant Benzothiazole and Benzimidazole Derivatives

Bharti      Chauhan; Rajnish      Kumar; Avijit      Mazumder; Salahuddin; Himanshu      Singh; Ranjeet   Kumar   Yadav; Mohd. Mustaqeem      Abdullah
doi:10.2174/03666220606143616
Abstract

Epilepsy is a chronic neurological disorder characterized by periodic and unpredictable seizures affecting the neurobiological, psychological, cognitive, economic, and social well-being of patients. It is one of the causes of concern in developed as well as developing countries as currently marketed drugs are not capable of providing protection against it. Although several heterocyclic moieties have been frequently used as building blocks for the preparation of anticonvulsant drugs, more focused and consistent research on the synthesis of potential molecules with less adverse effects is the need of the hour. It can be concluded on the basis of available research reports that among several heterocyclic compounds, benzo-fused five-membered heterocyclic moieties (benzothiazole and benzimidazole) have been utilized far less than their great potential as building blocks for the synthesis of anticonvulsant drugs. Various reports clearly established that the required pharmacophore model could be easily achieved through benzothiazole and benzimidazole moieties as two hetero atoms and aryl rings are present in the structure. The present study highlights various synthetic approaches for anticonvulsant benzothiazole and benzimidazole derivatives with their structure-activity relationship studies in order to provide a trove of knowledge to medicinal chemists for future research.
Keywords: Epilepsy, Benzothiazole, Benzimidazole, Synthetic Approaches, Anticonvulsant, Structure-Activity Relationship
« Previous Next »
Graphical Abstract

[1]
Pal, R.; Kumar, B.; Akhtar, M.J.; Chawla, P.A. Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies. Bioorg. Chem.,  2021, 115, 105230.
 [http://dx.doi.org/10.1016/j.bioorg.2021.105230] [PMID:  34416507]

[2]
Hirtz, D.; Thurman, D.J.; Gwinn-Hardy, K.; Mohamed, M.; Chaudhuri, A.R.; Zalutsky, R. How common are the “common” neurologic disorders? Neurology,  2007, 68(5), 326-337.
 [http://dx.doi.org/10.1212/01.wnl.0000252807.38124.a3] [PMID:  17261678]

[3]
Pal, R.; Singh, K.; Paul, J.; Khan, S.A.; Naim, M.J.; Akhtar, M.J. Overview of chemistry and therapeutic potential of non-nitrogen heterocyclics as anticonvulsant agents. Curr. Neuropharmacol.,  2021, 19.
 [http://dx.doi.org/10.2174/1570159X19666210803144815] [PMID:  34344289]

[4]
Levy, R.H.; Mattson, R.H.; Meldrum, B.S. Antiepileptic drugs, 5th ed; Lippincott Williams & Wilkins: Philadelphia, 2002. 

[5]
Perucca, E. An introduction to antiepileptic drugs. Epilepsia,  2005, 46(Suppl. 4), 31-37.
 [http://dx.doi.org/10.1111/j.1528-1167.2005.463007.x] [PMID:  15968807]

[6]
Rochat, P.; Hallas, J.; Gaist, D.; Friis, M.L. Antiepileptic drug utilization: A Danish prescription database analysis. Acta Neurol. Scand.,  2001, 104(1), 6-11.
 [http://dx.doi.org/10.1034/j.1600-0404.2001.00197.x] [PMID:  11442436]

[7]
Stafstrom, C.E.; Carmant, L. Seizures and epilepsy: An overview for neuroscientists. Cold Spring Harb. Perspect. Med.,  2015, 5(6), a022426.
 [http://dx.doi.org/10.1101/cshperspect.a022426] [PMID:  26033084]

[8]
Kumar, S.P. Synthesis of starting heterocycles: 2-aminobenzothiazoles, 2-aminothiazoles and 2-aminobenzenethiolspotential precursors for macroheterocycles 2018, 11(3), 316.(321)

[9]
Ul-Firdaus, J.; Siddiqui, N.; Sahu, M.; Alam, O. A comprehensive review: benzothiazoles as emerging nucleus of biological activities. Eur. J. Biomed. & Pharm. Sci.,  2018, 5(2), 216-229.

[10]
Keri, R.S.; Hiremathad, A.; Budagumpi, S.; Nagaraja, B.M. Comprehensive review in current developments of benzimidazole‐based medicinal chemistry. Chem. Biol. Drug Des.,  2015, 86(1), 19-65.
 [http://dx.doi.org/10.1111/cbdd.12462] [PMID:  25352112]

[11]
Hutchinson, I.; Jennings, S.A.; Vishnuvajjala, B.R.; Westwell, A.D.; Stevens, M.F. Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. J. Med. Chem.,  2002, 45(3), 744-747.
 [http://dx.doi.org/10.1021/jm011025r] [PMID:  11806726]

[12]
Abdelgawad, M.A.; Bakr, R.B.; Omar, H.A. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Bioorg. Chem.,  2017, 74, 82-90.
 [http://dx.doi.org/10.1016/j.bioorg.2017.07.007] [PMID:  28772160]

[13]
Irfan, A.; Batool, F.; Zahra Naqvi, S.A.; Islam, A.; Osman, S.M.; Nocentini, A.; Alissa, S.A.; Supuran, C.T. Benzothiazole derivatives as anticancer agents. J. Enzyme Inhib. Med. Chem.,  2020, 35(1), 265-279.
 [http://dx.doi.org/10.1080/14756366.2019.1698036] [PMID:  31790602]

[14]
Guan, Q.; Han, C.; Zuo, D.; Zhai, M.; Li, Z.; Zhang, Q.; Zhai, Y.; Jiang, X.; Bao, K.; Wu, Y.; Zhang, W. Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities. Eur. J. Med. Chem.,  2014, 87, 306-315.
 [http://dx.doi.org/10.1016/j.ejmech.2014.09.071] [PMID:  25262051]

[15]
Rashid, M. Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent. Bioorg. Chem.,  2020, 96, 103576.
 [http://dx.doi.org/10.1016/j.bioorg.2020.103576] [PMID:  31986463]

[16]
Asiri, Y.I.; Alsayari, A.; Muhsinah, A.B.; Mabkhot, Y.N.; Hassan, M.Z. Benzothiazoles as potential antiviral agents. J. Pharm. Pharmacol.,  2020, 72(11), 1459-1480.
 [http://dx.doi.org/10.1111/jphp.13331] [PMID:  32705690]

[17]
Tonelli, M.; Paglietti, G.; Boido, V.; Sparatore, F.; Marongiu, F.; Marongiu, E.; La Colla, P.; Loddo, R. Antiviral activity of benzimidazole derivatives. I. Antiviral activity of 1-substituted-2-[(benzotriazol-1/2-yl)methyl]benzimidazoles. Chem. Biodivers.,  2008, 5(11), 2386-2401.
 [http://dx.doi.org/10.1002/cbdv.200890203] [PMID:  19035566]

[18]
Hadanu, R.; Idris, S.; Sutapa, I.W. QSAR analysis of benzothiazole derivatives of antimalarial compounds based on AM1 semi-empirical method. Indones. J. Chem.,  2015, 15(1), 86-92.
 [http://dx.doi.org/10.22146/ijc.21228]

[19]
Thakkar, S.S.; Thakor, P.; Ray, A.; Doshi, H.; Thakkar, V.R. Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities. Bioorg. Med. Chem.,  2017, 25(20), 5396-5406.
 [http://dx.doi.org/10.1016/j.bmc.2017.07.057] [PMID:  28789907]

[20]
Haroun, M.; Tratrat, C.; Kositsi, K.; Tsolaki, E.; Petrou, A.; Aldhubiab, B.; Attimarad, M.; Harsha, S.; Geronikaki, A.; Venugopala, K.N.; Elsewedy, H.S.; Sokovic, M.; Glamoclija, J.; Ciric, A. New benzothiazole-based thiazolidinones as potent antimicrobial agents. Design, synthesis and biological evaluation. Curr. Top. Med. Chem.,  2018, 18(1), 75-87.
 [http://dx.doi.org/10.2174/1568026618666180206101814] [PMID:  29412109]

[21]
Alasmary, F.A.; Snelling, A.M.; Zain, M.E.; Alafeefy, A.M.; Awaad, A.S.; Karodia, N. Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents. Molecules,  2015, 20(8), 15206-15223.
 [http://dx.doi.org/10.3390/molecules200815206] [PMID:  26307956]

[22]
Bhavsar, Z.A.; Acharya, P.T.; Jethava, D.J.; Patel, H.D. Recent advances in development of anthelmintic agents: Synthesis and biological screening. Synth. Commun.,  2020, 50(7), 917-946.
 [http://dx.doi.org/10.1080/00397911.2019.1695276]

[23]
Flores-Carrillo, P.; Velázquez-López, J.M.; Aguayo-Ortiz, R.; Hernández-Campos, A.; Trejo-Soto, P.J.; Yépez-Mulia, L.; Castillo, R. Synthesis, antiprotozoal activity, and chemoinformatic analysis of 2-(methylthio)-1H-benzimidazole-5-carboxamide derivatives: Identification of new selective giardicidal and trichomonicidal compounds. Eur. J. Med. Chem.,  2017, 137, 211-220.
 [http://dx.doi.org/10.1016/j.ejmech.2017.05.058] [PMID:  28595066]

[24]
Zheng, X.J.; Li, C.S.; Cui, M.Y.; Song, Z.W.; Bai, X.Q.; Liang, C.W.; Wang, H.Y.; Zhang, T.Y. Synthesis, biological evaluation of benzothiazole derivatives bearing a 1,3,4-oxadiazole moiety as potential anti-oxidant and anti-inflammatory agents. Bioorg. Med. Chem. Lett.,  2020, 30(13), 127237.
 [http://dx.doi.org/10.1016/j.bmcl.2020.127237] [PMID:  32386981]

[25]
Gaba, M.; Singh, S.; Mohan, C. Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents. Eur. J. Med. Chem.,  2014, 76, 494-505.
 [http://dx.doi.org/10.1016/j.ejmech.2014.01.030] [PMID:  24602792]

[26]
Wang, J.; Yang, Y.; Li, Y.; Wang, Y. Computational study exploring the interaction mechanism of benzimidazole derivatives as potent cattle bovine viral diarrhea virus inhibitors. J. Agric. Food Chem.,  2016, 64(29), 5941-5950.
 [http://dx.doi.org/10.1021/acs.jafc.6b01067] [PMID:  27355875]

[27]
Bhagdev, K.; Sarkar, S. Benzothiazole: As an antidiabetic agent. Ann. Rom. Soc. Cell Biol.,  2021, 20269-20285.

[28]
Kumar, J.R.; Jawahar, L.J.; Pathak, D.P. Synthesis of benzimidazole derivatives: As anti-hypertensive agents. E-J. Chem.,  2006, 3(4), 278-285.
 [http://dx.doi.org/10.1155/2006/765712]

[29]
Noor, A.; Qazi, N.G.; Nadeem, H.; Khan, A.U.; Paracha, R.Z.; Ali, F.; Saeed, A. Synthesis, characterization, anti-ulcer action and molecular docking evaluation of novel benzimidazole-pyrazole hybrids. Chem. Cent. J.,  2017, 11(1), 85.
 [http://dx.doi.org/10.1186/s13065-017-0314-0] [PMID:  29086868]

[30]
Nile, S.H.; Kumar, B.; Park, S.W. In vitro evaluation of selected benzimidazole derivatives as an antioxidant and xanthine oxidase inhibitors. Chem. Biol. Drug Des.,  2013, 82(3), 290-295.
 [http://dx.doi.org/10.1111/cbdd.12141] [PMID:  23581708]

[31]
Yousif, E.; Adel, H.; Haddad, R.; Yusop, R. Effect of benzothiazole complexes on photodegrdation rate constants of polyvinyl chloride films. Yanbu J. Eng. Sci.,  2021, 10(1), 41-48.
 [http://dx.doi.org/10.53370/001c.24238]

[32]
Spasov, A.A.; Kalitin, K.Y.; Grechko, O.Y.; Anisimova, V.A. Antiepileptic activity of a new derivative of benzimidazole RU-1205. Bull. Exp. Biol. Med.,  2016, 160(3), 336-339.
 [http://dx.doi.org/10.1007/s10517-016-3164-1] [PMID:  26742743]

[33]
Vasil’ev, P.M.; Kalitin, K.Y.; Spasov, A.A.; Grechko, O.Y.; Poroikov, V.V.; Filimonov, D.A.; Anisimova, V.A. Prediction and study of anticonvulsant properties of benzimidazole derivatives. Pharm. Chem. J.,  2017, 50(12), 775-780.
 [http://dx.doi.org/10.1007/s11094-017-1530-6]

[34]
Mignani, S.; Majoral, J.P.; Desaphy, J.F.; Lentini, G. From riluzole to dexpramipexole via substituted-benzothiazole derivatives for amyotrophic lateral sclerosis disease treatment: Case studies. Molecules,  2020, 25(15), 3320.
 [http://dx.doi.org/10.3390/molecules25153320] [PMID:  32707914]

[35]
Siddiqui, N.; Alam, M.S.; Sahu, M.; Yar, M.S.; Alam, O.; Siddiqui, M.J. Antidepressant, analgesic activity and SAR studies of substituted benzimidazoles. Asian J. Pharm. Res.,  2016, 6(3), 170-174.
 [http://dx.doi.org/10.5958/2231-5691.2016.00024.1]

[36]
Abrol, S.; Bodla, R.B.; Goswami, C. A comprehensive review on benzothiazole derivatives for their biological activities. Int. J. Pharm. Sci. Res.,  2019, 10(7), 3196-09.

[37]
Yadav, S; Narasimhan, B Perspectives of benzimidazole derivatives as anticancer agents in the new era. Anti-Cancer Agents Med.Chem., (Formerly Current Medicinal Chemistry-Anti-CancerAgents),.,  2016, 16(11), 1403-25.
 [http://dx.doi.org/ 10.2174/1871520616666151103113412]

[38]
Nath, R.; Yar, M.S.; Pathania, S.; Grover, G.; Debnath, B.; Akhtar, M.J. Synthesis and anticonvulsant evaluation of indoline derivatives of functionalized aryloxadiazole amine and benzothiazole acetamide. J. Mol. Struct.,  2021, 1228, 129742.
 [http://dx.doi.org/10.1016/j.molstruc.2020.129742]

[39]
Dean, P.; Gale, K. Anticonvulsant action of GABA receptor blockade in the nigrotectal target region. Brain Res.,  1989, 477(1-2), 391-395.
 [http://dx.doi.org/10.1016/0006-8993(89)91434-0] [PMID:  2539235]

[40]
Errington, A.C.; Stöhr, T.; Lees, G. Voltage gated ion channels: Targets for anticonvulsant drugs. Curr. Top. Med. Chem.,  2005, 5(1), 15-30.
 [http://dx.doi.org/10.2174/1568026053386872] [PMID:  15638775]

[41]
Ng, G.Y. Bertrand, S.; Sullivan, R.; Ethier, N.; Wang, J.; Yergey, J.; Belley, M.; Trimble, L.; Bateman, K.; Alder, L.; Smith, A.; McKernan, R.; Metters, K.; O’Neill, G.P.; Lacaille, J.C.; Hébert, T.E. γ-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol.,  2001, 59(1), 144-152.
 [http://dx.doi.org/10.1124/mol.59.1.144] [PMID:  11125035]

[42]
Landmark, C.J. Targets for antiepileptic drugs in the synapse. Med. Sci. Monit.,  2007, 13(1), RA1-RA7.
 [PMID:  17179916]

[43]
Alexander, A.; Alexander, F.; Kern, M.A.; David, N.R.; Claus, R. Benzothiazole derivatives. Canadian patent 02413086, 2002.

[44]
Cusack, K.P.; Scott, B.; Arnold, L.D.; Ericsson, A.M. Benzothiazole derivatives. US Patent 2003O153568A1, 2003.

[45]
Jan’min, V; Uil’jam, K; Chester, M Benzothiazole derivatives, pharmaceutical composition exhibiting property to bind amyloid and method for detecting amyloid deposits in mammal. federation 2440995 C2, 2004.

[46]
Pascale, G.; Pierre, G.J.; Alain, V.P. Benzothiazole derivatives for the treatment of diabetes. Australian patent office 2004271740, 2005.

[47]
Alexander, F.; Claus, R. Benzothiazole derivatives International. patent WO2006008041A1, 2006.

[48]
Peter, S.J.O.; Peter, S. Novel use of benzothiazole derivatives European. Patent 1539723B1, 2005.

[49]
Theodoridis, G.; Barron, E.J.; Suarez, D.P.; Zhang, Y.L.; Ding, P.; Lyga, J.W.; Whiteside, M.P. Pesticidal (Dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives US Patent 7208450B2, 2007.

[50]
Schumacher, R.; Ma, J.; Danca, M.D.; Xie, W.; Nguyen, T.M.; Tehim, A. 1H-indazoles, Benzothiazoles, 1,2-Benzoisoxazoles, 1,2-Benzoisothiazoles, and chromones and preparation and uses there of. US patent 20070135417A1, 2007.

[51]
Cowart, M.D.; Minghua, S.; Chen, Z.; Guo, Z.Z. Benzothiazole cyclobutyl amine derivatives. US Patent 7,576,110 B2, 2009.

[52]
Albert, E.; Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S. 6-triazolopyridazine sulfanyl benzothiazole derivatives as MET inhibitors US Patent 9321777 B2, 2016.

[53]
Yamasaki, N.; Imoto, T.; Murai, Y.; Hiramura, T.; Oku, T.; Sawada, K. Benzimidazole derivatives. Australian. Patent 199712095 B2, 2000.

[54]
Yuntae, K.; Barbara, H. Carbonylamino-benzimidazole derivatives as androgen receptor modulators. Australian. Patent 2003286757B2, 2004.

[55]
Ritzeler, O.; Jaehne, G. Indole derivatives or benzimidazole derivatives for modulating IKB kinase. US Patent 7285560 B2, 2007.

[56]
Frenkel, AD; Lively, SE; Powers, JP; Smith, A; Sun, D; Tomooka, C Wang, Z Benzimidazole derivatives US Patent7635774 B2, 2009.

[57]
C, BB.; Qun, D.; S., GT.; Hongjian, J; Sun, D Novel cyclic benzimidazole derivatives useful anti-diabetic agents. Canadian intellectualproperty 2737694, 2011.

[58]
Coates, Magana; DD, Gonzales; Dp, Catalina; DP, Paredes; G, Gelbert Substituted benzimidazole derivatives as protein kinase inhibitors. Canadian intellectual propert 2747055, 2014.

[59]
Poitout, L.; Brault, V.; Ferrandis, E.; Thurieau, C. Benzimidazole derivatives and their use as a medicament. US Patent 8236965 B2, 2012.

[60]
Ng, R.; Sui, Z.; Guan, J.; Lanter, J.C. Jr Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS). US Patent 8586616 B2, 2013.

[61]
Koen, V.; David, M.G.; Bernard, R.P.J.M. Bis-benzimidazole derivatives European. Patent 2473503 B1, 2014.

[62]
Yun, L. Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer Australian. Patent 2015231202 B2, 2015.

[63]
David, M.G.; Dominique, S.D.; Julien, S.L.; Roboisson, V.K.; Bernard, P.J.M. Bis-benzimidazole derivatives as hepatitis C virus inhibitors Australian. Patent 2010280712 B2, 2015.

[64]
C, BB.; Qun, D.; S., GT.; Hongjian, J.; Michael, CD.; Jianming, B.; Jinlong, J.; Andy, K. Novel cyclic benzimidazole derivatives useful anti-diabetic agents. European Patent 2348857, 2016.

[65]
Tafesse, L.; Yao, J.; Zhou, X. Benzimidazole derivatives and use thereof. US Patent 9975858 B2, 2018.

[66]
Qiu, Y.L.; Wang, C.; Ying, L.; Or, Y.S. Benzimidazole derivatives. US Patent 10017499 B2, 2018.

[67]
Tedesco, R.; Qu, J.; Sanchez, R.; Rivero, R.A. Benzimidazole derivatives as PI3 kinase inhibitors US Patent 10660898 B2, 2020.

[68]
Chopade, R.S.; Bahekar, R.H.; Khedekar, P.B.; Bhusari, K.P.; Rao, A.R. Synthesis and anticonvulsant activity of 3-(6-substituted-benzothiazol-2-yl)-6-phenyl-[1, 3]-xazinane-2-thiones. Arch. Pharm. (Weinheim),  2002, 335(8), 381-388.
 [http://dx.doi.org/10.1002/1521-4184(200211)335:8<381:AID-ARDP381>3.0.CO;2-S] [PMID:  12397622]

[69]
Yogeeswari, P.; Sriram, D.; Mehta, S.; Nigam, D.; Kumar, M.M.; Murugesan, S.; Stables, J.P. Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones. Farmaco,  2005, 60(1), 1-5.
 [http://dx.doi.org/10.1016/j.farmac.2004.09.001] [PMID:  15652361]

[70]
Siddiqui, N.; Pandeya, S.N.; Khan, S.A.; Stables, J.; Rana, A.; Alam, M.; Arshad, M.F.; Bhat, M.A. Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain. Bioorg. Med. Chem. Lett.,  2007, 17(1), 255-259.
 [http://dx.doi.org/10.1016/j.bmcl.2006.09.053] [PMID:  17046248]

[71]
Siddiqui, N.; Rana, A.; Khan, S.A.; Bhat, M.A.; Haque, S.E. Synthesis of benzothiazole semicarbazones as novel anticonvulsants--the role of hydrophobic domain. Bioorg. Med. Chem. Lett.,  2007, 17(15), 4178-4182.
 [http://dx.doi.org/10.1016/j.bmcl.2007.05.048] [PMID:  17572089]

[72]
Laddha, S.S.; Bhatnagar, S.P. Rapid microwave-assisted solution phase synthesis of 6, 8-disubstituted 2-phenyl-3-(substituted-benzothiazol-2-yl)-4-[3 H]-quinazolinones as novel anticonvulsants. Phosphorus Sulfur Silicon Relat. Elem.,  2008, 183(9), 2262-2273.
 [http://dx.doi.org/10.1080/10426500801957766]

[73]
Siddiqui, N.; Ahsan, W. Benzothiazole incorporated barbituric acid derivatives: synthesis and anticonvulsant screening. Arch. Pharm. (Weinheim),  2009, 342(8), 462-468.
 [http://dx.doi.org/10.1002/ardp.200900002] [PMID:  19565603]

[74]
Siddiqui, N.; Rana, A.; Khan, S.A.; Haque, S.E.; Arshad, M.F.; Ahmed, S.; Ahsan, W. Synthesis and preliminary screening of benzothiazol-2-yl thiadiazole derivatives for anticonvulsant activity. Acta Pharm.,  2009, 59(4), 441-451.
 [http://dx.doi.org/10.2478/v10007-009-0031-x] [PMID:  19919933]

[75]
Amnerkar, N.D.; Bhusari, K.P. Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. Eur. J. Med. Chem.,  2010, 45(1), 149-159.
 [http://dx.doi.org/10.1016/j.ejmech.2009.09.037] [PMID:  19853976]

[76]
Ugale, V.G.; Patel, H.M.; Wadodkar, S.G.; Bari, S.B.; Shirkhedkar, A.A.; Surana, S.J. Quinazolino-benzothiazoles: Fused pharmacophores as anticonvulsant agents. Eur. J. Med. Chem.,  2012, 53, 107-113.
 [http://dx.doi.org/10.1016/j.ejmech.2012.03.045] [PMID:  22534186]

[77]
Amir, M.; Asif, S.; Ali, I.; Hassan, M.Z. Synthesis of benzothiazole derivatives having acetamido and carbothioamido pharmacophore as anticonvulsant agents. Med. Chem. Res.,  2012, 21(9), 2661-2670.
 [http://dx.doi.org/10.1007/s00044-011-9791-1]

[78]
Kumar, P.; Shrivastava, B.; Pandeya, S.N.; Tripathi, L.; Stables, J.P. Design, synthesis, and anticonvulsant evaluation of some novel 1, 3 benzothiazol-2-yl hydrazones/acetohydrazones. Med. Chem. Res.,  2012, 21(9), 2428-2442.
 [http://dx.doi.org/10.1007/s00044-011-9768-0]

[79]
Hassan, M.Z.; Khan, S.A.; Amir, M. Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotective. Eur. J. Med. Chem.,  2012, 58, 206-213.
 [http://dx.doi.org/10.1016/j.ejmech.2012.10.002] [PMID:  23124217]

[80]
Navale, A.; Pawar, S.; Deodhar, M.; Kale, A. Synthesis of substituted benzo [d] thiazol-2-ylcarbamates as potential anticonvulsants. Med. Chem. Res.,  2013, 22(9), 4316-4321.
 [http://dx.doi.org/10.1007/s00044-012-0434-y]

[81]
Malik, S.; Bahare, R.S.; Khan, S.A. Design, synthesis and anticonvulsant evaluation of N-(benzo[d]thiazol-2-ylcarbamoyl)-2-methyl-4-oxoquinazoline-3(4H)-carbothioamide derivatives: A hybrid pharmacophore approach. Eur. J. Med. Chem.,  2013, 67, 1-13.
 [http://dx.doi.org/10.1016/j.ejmech.2013.06.026] [PMID:  23831504]

[82]
Siddiqui, N.; Ahuja, P.; Malik, S.; Arya, S.K. Design of benzothiazole-1,3,4-thiadiazole conjugates: Synthesis and anticonvulsant evaluation. Arch. Pharm. (Weinheim),  2013, 346(11), 819-831.
 [http://dx.doi.org/10.1002/ardp.201300083] [PMID:  24081512]

[83]
Ali, R.; Siddiqui, N. New benzo[d]thiazol-2-yl-aminoacetamides as potential anticonvulsants: Synthesis, activity and prediction of molecular properties. Arch. Pharm. (Weinheim),  2015, 348(4), 254-265.
 [http://dx.doi.org/10.1002/ardp.201400466] [PMID:  25782176]

[84]
Liu, D.C.; Zhang, H.J.; Jin, C.M.; Quan, Z.S. Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticonvulsant agents. Molecules,  2016, 21(3), 164.
 [http://dx.doi.org/10.3390/molecules21030164] [PMID:  26938519]

[85]
Siddiqui, N.; Alam, M.S.; Sahu, M.; Naim, M.J.; Yar, M.S.; Alam, O. Design, synthesis, anticonvulsant evaluation and docking study of 2-[(6-substituted benzo[d]thiazol-2-ylcarbamoyl)methyl]-1-(4-substituted phenyl)isothioureas. Bioorg. Chem.,  2017, 71, 230-243.
 [http://dx.doi.org/10.1016/j.bioorg.2017.02.009] [PMID:  28238402]

[86]
Choudhary, S.; Kalra, N.; Jeyabalan, G. Synthesis, characterization and pharmacological evaluation of some newer Benzothiazole derivatives. Indian J. Pharm. Biol. Res.,  2018, 6(02), 31-36.
 [http://dx.doi.org/10.30750/ijpbr.6.2.6]

[87]
Firdaus, J.U.; Habib, A.; Siddiqui, N.; Alam, O.; Naim, M.J.; Partap, S.; Sahu, M. Design, synthesis, and molecular docking study of benzothiazolotriazine derivatives for anticonvulsant potential. Arch. Pharm. (Weinheim),  2018, 351(12), e1800154.
 [http://dx.doi.org/10.1002/ardp.201800154] [PMID:  30479053]

[88]
Jamal Gilani, S.; Zaheen Hassan, M.; Sarim Imam, S.; Kala, C.; Prakash Dixit, S. Novel benzothiazole hydrazine carboxamide hybrid scaffolds as potential in vitro GABA AT enzyme inhibitors: Synthesis, molecular docking and antiepileptic evaluation. Bioorg. Med. Chem. Lett.,  2019, 29(14), 1825-1830.
 [http://dx.doi.org/10.1016/j.bmcl.2019.05.007] [PMID:  31084949]

[89]
Jin, Q.; Fu, Z.; Guan, L.; Jiang, H. Syntheses of Benzo[d]Thiazol-2(3H)-One derivatives and their antidepressant and anticonvulsant effects. Mar. Drugs,  2019, 17(7), 430.
 [http://dx.doi.org/10.3390/md17070430] [PMID:  31340514]

[90]
Khokra, S.L.; Arora, K.; Khan, S.A.; Kaushik, P.; Saini, R.; Husain, A. Synthesis, computational studies and anticonvulsant activity of novel benzothiazole coupled sulfonamide derivatives. Iranian journal of pharmaceutical research. Iran. J. Pharm. Res.,  2019, 18(1), 1-15.
 [PMID:  31089339]

[91]
Singh, R.; Sharma, S.; Banarasi, B. Synthesis, characterization and evaluation of 2-imino benzothiazole derivatives as anticonvulsant agents. Int. J. Pharm. Sci. Res.,  2014, 5, 213-217.

[92]
Chimirri, A.; De Sarro, A.; De Sarro, G.; Gitto, R.; Zappalà, M. Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives. Farmaco,  2001, 56(11), 821-826.
 [http://dx.doi.org/10.1016/S0014-827X(01)01147-8] [PMID:  11765033]

[93]
Anandarajagopal, K.; Tiwari, R.N.; Bothara, K.G.; Sunilson, J.A.; Dineshkumar, C.; Promwichit, P. 2-mercaptobenzimidazole derivatives: Synthesis and anticonvulsant activity. Adv. Appl. Sci. Res.,  2010, 1(2), 132-138.

[94]
Shingalapur, R.V.; Hosamani, K.M.; Keri, R.S.; Hugar, M.H. Derivatives of benzimidazole pharmacophore: Synthesis, anticonvulsant, antidiabetic and DNA cleavage studies. Eur. J. Med. Chem.,  2010, 45(5), 1753-1759.
 [http://dx.doi.org/10.1016/j.ejmech.2010.01.007] [PMID:  20122763]

[95]
Jain, P.; Sharma, P.K.; Rajak, H.; Pawar, R.S.; Patil, U.K.; Singour, P.K. Design, synthesis and biological evaluation of some novel benzimidazole derivatives for their potential anticonvulsant activity. Arch. Pharm. Res.,  2010, 33(7), 971-980.
 [http://dx.doi.org/10.1007/s12272-010-0701-8] [PMID:  20661705]

[96]
Shaikh, I.N.; Hosamani, K.M.; Seetharamareddy, H.R.; Hugar, M.H. Synthesis and in-vivo evaluation of carbonyl-amide linkage based new benzimidazole derivatives. Arch. Pharm. (Weinheim),  2012, 345(1), 65-72.
 [http://dx.doi.org/10.1002/ardp.201100068] [PMID:  21953492]

[97]
Bhrigu, B.; Siddiqui, N.; Pathak, D.; Alam, M.S.; Ali, R.; Azad, B. Anticonvulsant evaluation of some newer benzimidazole derivatives: Design and synthesis. Acta Pol. Pharm.,  2012, 69(1), 53-62.
 [PMID:  22574507]

[98]
Kumar, S.; Scholar, D.P. Synthesis, characterization and evaluation for anticonvulsant activity of acetylnaphthalene and substituted Acetylenaphthalene derivative of heterocyclic compounds. Pharma Innov.,  2013, 1(11)

[99]
Dangi, G.; Kumar, N.; Sharma, C.S.; Chauhan, L.S. Synthesis, anticonvulsant activity of some novel benzimidazole Acetohydrazides. J. Drug Deliv. Ther.,  2014, 4(2), 182-185.
 [http://dx.doi.org/10.22270/jddt.v4i2.938]

[100]
Al-Karagully, H.J.; Mahmood, A.A.; Al-Shawi, N.N.; Fadhil, A.A. Synthesis, characterization and anticonvulsant evaluation of new derivatives derived from 5-methoxy-2-mercapto benzimidazole. Pharm. Lett.,  2016, 8(18), 96-101.

[101]
Siddiqui, N.; Alam, M.S.; Ali, R.; Yar, M.S.; Alam, O. Synthesis of new benzimidazole and phenylhydrazinecarbothiomide hybrids and their anticonvulsant activity. Med. Chem. Res.,  2016, 25(7), 1390-1402.
 [http://dx.doi.org/10.1007/s00044-016-1570-6]

[102]
Shaharyar, M.; Mazumder, A.; Garg, R.; Pandey, R.D. Synthesis, characterization and pharmacological screening of novel benzimidazole derivatives. Arab. J. Chem.,  2016, 9, S342-S347.
 [http://dx.doi.org/10.1016/j.arabjc.2011.04.013]

[103]
Karataş M.O.; Uslu, H.; Sarı S.; Alagöz, M.A.; Karakurt, A.; Alıcı B.; Bilen, C.; Yavuz, E.; Gencer, N.; Arslan, O. Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies. J. Enzyme Inhib. Med. Chem.,  2016, 31(5), 760-772.
 [http://dx.doi.org/10.3109/14756366.2015.1063624] [PMID:  26207513]

[104]
Chikkula, K.V.; Raja, S. Design and synthesis of novel substituted benzimidazole analogs as potent anticonvulsant agents. Eur. J. Biomed.,  2017, 4(8), 749-758.

[105]
Partap, S.; Yar, M.S.; Hassan, M.Z.; Akhtar, M.J.; Siddiqui, A.A. Design, synthesis, and pharmacological screening of pyridazinone hybrids as anticonvulsant agents. Arch. Pharm. (Weinheim),  2017, 350(10), 1700135.
 [http://dx.doi.org/10.1002/ardp.201700135] [PMID:  28863231]

[106]
Prasad, P.M.; Sundararajan, R. Design and synthesis of novel 2-(5-(4-aryl)-4, 5-dihydro-1 H-pyrazol-3-yl)-1-(substituted aminomethyl)-1 H-benzimidazole as potent anticonvulsants. Med. Chem. Res.,  2017, 26(12), 3158-3172.
 [http://dx.doi.org/10.1007/s00044-017-2010-y]

[107]
Sahoo, B.M.; Banik, B.K.; Rao, N.S.; Raju, B. Microwave assisted green synthesis of benzimidazole derivatives and evaluation of their anticonvulsant activity. Curr. Microw. Chem.,  2019, 6(1), 23-29.
 [http://dx.doi.org/10.2174/2213335606666190429124745]

[108]
Kumar, R; Abdullah, M.M. Synthesis, characterization and anticonvulsant potential of 2,5-disubstituted 1,3,4-oxadiazole analogues. Asian J. Chem,,  2019, 31(6), 1389-97.